FPS
CLB icon

Fieldpoint Private Securities’s Core Laboratories CLB Stock Holding History

Fieldpoint Private Securities’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,955
Closed -$450K – 311
2019
Q4 		$450K Buy
11,955
+890
+8% +$40K 0.13% 167
2019
Q3 		$516K Buy
11,065
+210
+2% +$9.76K 0.19% 135
2019
Q2 		$567K Buy
+10,855
New +$637K 0.18% 143
2018
Q1 		– Sell
-4,152
Closed -$455K – 409
2017
Q4 		$455K Sell
4,152
-1,824
-31% -$182K 0.24% 104
2017
Q3 		$590K Buy
+5,976
New +$579K 0.25% 102
2017
Q2 		– Sell
-200
Closed -$23K – 177
2017
Q1 		$23K Buy
+200
New +$23.2K 0.02% 257

Other funds holding CLB

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fieldpoint Private Securities's CLB Position: Q1 2020 in Review

Fieldpoint Private Securities sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 11,955 shares — an estimated $450K sold.

Fieldpoint Private Securities first reported a position in CLB in Q1 2017 and held it in 6 quarters. The position peaked at $590K in Q3 2017. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Fieldpoint Private Securities reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Fieldpoint Private Securities sold 11,955 Core Laboratories shares in Q1 2020, an estimated $450K.
  • Fieldpoint Private Securities first reported a position in Core Laboratories in Q1 2017 and held it in 6 quarters.
  • Fieldpoint Private Securities's Core Laboratories position peaked at $590K in Q3 2017.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Fieldpoint Private Securities's 13F filing for Q1 2020, filed 11 May 2020.